Koers Reata Pharmaceuticals, Inc.
Aandelen
RETA
US75615P1030
Biotechnologie & Medisch Onderzoek
Recentste transcriptie over Reata Pharmaceuticals, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 60 | 26-09-23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Mike Visnick
PRN | Corporate Officer/Principal | - | 01-01-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 26-09-23 | |
Michael Dambach
BRD | Director/Board Member | - | 26-09-23 |
Robin Kramer
BRD | Director/Board Member | - | 26-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 0 M€ | 0,00% | - | |
0.07% | 0 M€ | 0,00% | - | |
0.05% | 735 M€ | -.--% | - | |
0.04% | 464 M€ | -.--% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |